Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02355431
Title INCB039110 in Combination With Erlotinib in Non Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Incyte Corporation
Age Groups: adult
Covered Countries USA

No variant requirements are available.